A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin
Clinical trial NCT04118842 · COMPLETED
Trial details
- NCT number
- NCT04118842
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2020-02-26
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.